Watchlist Price Alert

X4 Pharmaceuticals Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

2.70

-0.12 (-4.26%)

At close: Jun 16, 2025, 3:59 PM

2.83

4.81%

After-hours: Jun 16, 2025, 06:55 PM EDT

-4.26% (1D)

Bid	2.69
Market Cap	15.63M
Revenue (ttm)	31.36M
Net Income (ttm)	14.6M
EPS (ttm)	2.11
PE Ratio (ttm)	1.28
Forward PE	-0.33
Analyst	Buy

Ask	3.29
Volume	724,397
Avg. Volume (20D)	176,349
Open	2.87
Previous Close	2.82
Day's Range	2.67 - 2.96
52-Week Range	2.67 - 31.20
Beta	0.66

About XFOR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XFOR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XFOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

X4 Pharmaceuticals Inc. is scheduled to release its earnings on Aug 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-12.99%

X4 Pharmaceuticals shares are trading lower. The c... Unlock content with Pro Subscription

2 months ago

-12.09%

X4 Pharmaceuticals shares are trading lower following a Q4 EPS miss.

News

1 month ago · seekingalpha.com

X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call Transcript

1 month ago · benzinga.com

Top 3 Health Care Stocks That May Rocket Higher In April

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

2 months ago · seekingalpha.com

X4 Pharmaceuticals, Inc. (XFOR) Q4 2024 Earnings Call Transcript

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Daniel Ferry - IR, LifeSci Advisors Paula Ragan - CEO Adam Mostafa - CFO Christo...